Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Affymetrix, Partners HealthCare collaborate

This article was originally published in The Gray Sheet

Executive Summary

Diagnostics firm inks three-year translational research agreement with Partners managed care organization to develop microassay-based diagnostics for newborn hearing loss, autism, hypertrophic cardiomyopathy and other conditions. Partners is an integrated healthcare delivery system comprising Brigham & Women's Hospital and Massachusetts General in Boston. Partners' researchers at Harvard Medical School will create and validate the microarray tests in Clinical Laboratory Improvement Amendments-regulated labs. Affymetrix' Translational Medicine Program develops molecular signatures to create custom-designed microarray products that help researchers diagnose and tailor treatments for individual patients...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT023959

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel